The drug maker is not going to pursue the sales of this drug on the world market. It is "supposed to" treat prostate cancer. However, studies indicate that it may actually INCREASE THE RISK of the most serious types of tumors.
There is no indication that they will remove it from the U.S. market. Men here will still be able to have their risk of tumor increased.
See this Amp at http://buswk.co/fTGw4N
No comments:
Post a Comment